PLUS1
35.91
0.46 (1.3%)
0.46 (1.3%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Pfizer Inc | PFE | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.46 | 1.3% | 35.91 | 04:35:24 |
| Close Price | Low Price | High Price | Open Price | Previous Close |
|---|---|---|---|---|
| 35.45 |
| Stock Trades | Traded Volume | Average Volume | 52 Week Range |
|---|---|---|---|
| 25 | 2,663 | 21,482,480 | 27.88 - 40.97 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 04:35:24 | formt | 100 | $ 35.91 | USD |
Pfizer Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 199.55B | 5.56B | 5.54B | $ 51.75B | $ 8.81B | 2.88 | 15.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 45.16M | $ 1.44 | 4.01% | - | - |
Pfizer News
| Date | Time | Source | News Article |
|---|---|---|---|
| 10/27/2020 | 16:14 | Dow Jones News | Pfizer Says Covid-19 Vaccine Late-Stage Trial Almost Fully.. |
| 10/27/2020 | 12:07 | Dow Jones News | Pfizer Says Covid-19 Vaccine Late-Stage Trial Almost Fully.. |
| 10/27/2020 | 08:28 | Dow Jones News | Pandemic Dents Third-Quarter Sales for Pfizer -- Update |
| 10/27/2020 | 07:59 | Dow Jones News | Pfizer Gets FDA Priority Review of Abrocitinib in Atopic.. |
| 10/27/2020 | 07:43 | Dow Jones News | Pfizer Posts Smaller 3Q Profit, Revenue as Demand Declines.. |
| 10/27/2020 | 07:42 | Dow Jones News | Pfizer Tightens 2020 Guidance |
| 10/27/2020 | 06:55 | Business Wire | FDA Grants Priority Review & EMA Accepts Regulatory.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PFE Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 37.08 | 38.285 | 35.32 | 37.25 | 29,248,491 | -1.17 | -3.16% |
| 1 Month | 36.93 | 38.8479 | 35.32 | 37.06 | 23,786,543 | -1.02 | -2.76% |
| 3 Months | 38.76 | 39.48 | 33.56 | 37.17 | 22,403,855 | -2.85 | -7.35% |
| 6 Months | 38.46 | 39.53 | 31.61 | 36.42 | 27,104,232 | -2.55 | -6.63% |
| 1 Year | 38.00 | 40.97 | 27.88 | 36.05 | 26,950,419 | -2.09 | -5.5% |
| 3 Years | 35.43 | 46.47 | 27.88 | 38.13 | 22,597,733 | 0.48 | 1.35% |
| 5 Years | 34.25 | 46.47 | 27.88 | 35.85 | 23,464,030 | 1.66 | 4.85% |
Pfizer Description
| Pfizer is one of the world's largest pharmaceutical firms, with annual sales over $50 billion. Pfizer also spends a leading amount on research and development, close to $8 billion annually. While Pfizer historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, neuroscience drug Lyrica, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor, representing over a fifth of total firm sales. |
